TY - JOUR
T1 - Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction
AU - Ishii, J.
AU - Wang, J.
AU - Naruse, H.
AU - Taga, S.
AU - Kinoshita, M.
AU - Kurokawa, H.
AU - Iwase, M.
AU - Kondo, T.
AU - Nomura, M.
AU - Nagamura, Y.
AU - Watanabe, Y.
AU - Hishida, H.
AU - Tanaka, T.
AU - Kawamura, K.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1997
Y1 - 1997
N2 - We compared the diagnostic utility of serum concentrations of human heart-type cytoplasmic fatty acid-binding protein (H-FABPc), myoglobin, and their ratio for the early diagnosis of acute myocardial infarction (AMI) in 104 healthy volunteers and 165 patients at admission within 6 h of the onset of chest pain. The ROC curves of the H-FABPc [0.946, 95% confidence interval (CI) = 0.913-0.979] and myoglobin (0.895, 95% CI = 0.8460.944) between patients with AMI and healthy volunteers were significantly greater than the area under the ratio of myoglobin to H-FABPc (0.823, 95% CI = 0.7650.881). In 165 patients, the sensitivity (81.8%, 95% CI = 74.2-89.4%), specificity (86.4%, 95% CI = 78.1-94.6%), and predictive accuracy (83.6%, 95% CI = 78.0- 89.3%) of H-FABPc >12 μg/L in, diagnosing AMI were significantly higher than those of myoglobin, and were similar to those of the combination of H-FABFc >12 μg/L and the ratio ≤14. We conclude that H-FABPc is a more sensitive and specific marker than myoglobin for the early diagnosis of AMI, and that their ratio cannot give a clear advantage over the measurement of H-FABPc alone.
AB - We compared the diagnostic utility of serum concentrations of human heart-type cytoplasmic fatty acid-binding protein (H-FABPc), myoglobin, and their ratio for the early diagnosis of acute myocardial infarction (AMI) in 104 healthy volunteers and 165 patients at admission within 6 h of the onset of chest pain. The ROC curves of the H-FABPc [0.946, 95% confidence interval (CI) = 0.913-0.979] and myoglobin (0.895, 95% CI = 0.8460.944) between patients with AMI and healthy volunteers were significantly greater than the area under the ratio of myoglobin to H-FABPc (0.823, 95% CI = 0.7650.881). In 165 patients, the sensitivity (81.8%, 95% CI = 74.2-89.4%), specificity (86.4%, 95% CI = 78.1-94.6%), and predictive accuracy (83.6%, 95% CI = 78.0- 89.3%) of H-FABPc >12 μg/L in, diagnosing AMI were significantly higher than those of myoglobin, and were similar to those of the combination of H-FABFc >12 μg/L and the ratio ≤14. We conclude that H-FABPc is a more sensitive and specific marker than myoglobin for the early diagnosis of AMI, and that their ratio cannot give a clear advantage over the measurement of H-FABPc alone.
UR - http://www.scopus.com/inward/record.url?scp=0030855627&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030855627&partnerID=8YFLogxK
U2 - 10.1093/clinchem/43.8.1372
DO - 10.1093/clinchem/43.8.1372
M3 - Article
C2 - 9267316
AN - SCOPUS:0030855627
SN - 0009-9147
VL - 43
SP - 1372
EP - 1378
JO - Clinical Chemistry
JF - Clinical Chemistry
IS - 8
ER -